2023 Q4 Form 10-Q Financial Statement
#000160706224000033 Filed on January 19, 2024
Income Statement
Concept | 2023 Q4 | 2022 Q4 |
---|---|---|
Revenue | $31.64K | $31.64K |
YoY Change | 0.0% | -46.44% |
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $134.3K | $427.4K |
YoY Change | -68.57% | 758.45% |
% of Gross Profit | ||
Research & Development | $47.53K | $95.51K |
YoY Change | -50.24% | -17.44% |
% of Gross Profit | ||
Depreciation & Amortization | ||
YoY Change | ||
% of Gross Profit | ||
Operating Expenses | $47.53K | $95.51K |
YoY Change | -50.24% | -42.28% |
Operating Profit | -$122.8K | -$463.9K |
YoY Change | -73.53% | 335.88% |
Interest Expense | $17.76K | $17.36K |
YoY Change | 2.33% | -99.38% |
% of Operating Profit | ||
Other Income/Expense, Net | -$227.0K | $0.00 |
YoY Change | -100.0% | |
Pretax Income | -$349.8K | $1.636M |
YoY Change | -121.38% | -38.16% |
Income Tax | ||
% Of Pretax Income | ||
Net Earnings | -$349.8K | $1.636M |
YoY Change | -121.38% | -38.16% |
Net Earnings / Revenue | -1105.44% | 5169.82% |
Basic Earnings Per Share | -$0.10 | $0.45 |
Diluted Earnings Per Share | -$0.10 | $0.43 |
COMMON SHARES | ||
Basic Shares Outstanding | 3.559M shares | 5.032B shares |
Diluted Shares Outstanding | 3.596M shares | 3.361M shares |
Balance Sheet
Concept | 2023 Q4 | 2022 Q4 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $124.5K | $40.74K |
YoY Change | 205.6% | -88.47% |
Cash & Equivalents | $124.5K | $40.74K |
Short-Term Investments | ||
Other Short-Term Assets | $5.000K | $19.09K |
YoY Change | -73.81% | -53.77% |
Inventory | ||
Prepaid Expenses | $14.09K | |
Receivables | $12.30K | $131.7K |
Other Receivables | $0.00 | $0.00 |
Total Short-Term Assets | $141.8K | $191.5K |
YoY Change | -25.97% | -70.13% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | ||
YoY Change | ||
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | $17.73K | $222.6K |
YoY Change | -92.03% | 136.59% |
Other Assets | ||
YoY Change | ||
Total Long-Term Assets | $17.73K | $222.6K |
YoY Change | -92.03% | 136.59% |
TOTAL ASSETS | ||
Total Short-Term Assets | $141.8K | $191.5K |
Total Long-Term Assets | $17.73K | $222.6K |
Total Assets | $159.5K | $414.1K |
YoY Change | -61.48% | -43.68% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $44.18K | $31.04K |
YoY Change | 42.35% | -3.87% |
Accrued Expenses | $1.663M | $1.614M |
YoY Change | 3.03% | -18.26% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $50.21K | $1.710K |
YoY Change | 2836.26% | -99.88% |
Long-Term Debt Due | $509.9K | $509.9K |
YoY Change | 0.0% | -59.92% |
Total Short-Term Liabilities | $5.247M | $5.299M |
YoY Change | -0.98% | -49.49% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Other Long-Term Liabilities | $154.0K | $0.00 |
YoY Change | ||
Total Long-Term Liabilities | $154.0K | $0.00 |
YoY Change | ||
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $5.247M | $5.299M |
Total Long-Term Liabilities | $154.0K | $0.00 |
Total Liabilities | $5.401M | $5.299M |
YoY Change | 1.93% | -49.49% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$20.10M | -$19.27M |
YoY Change | 4.3% | |
Common Stock | $376.00 | $504.8K |
YoY Change | -99.93% | |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | -$5.241M | -$4.885M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $159.5K | $414.1K |
YoY Change | -61.48% | -43.68% |
Cashflow Statement
Concept | 2023 Q4 | 2022 Q4 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$349.8K | $1.636M |
YoY Change | -121.38% | -38.16% |
Depreciation, Depletion And Amortization | ||
YoY Change | ||
Cash From Operating Activities | -$162.3K | -$10.46K |
YoY Change | 1451.52% | -96.25% |
INVESTING ACTIVITIES | ||
Capital Expenditures | ||
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | $0.00 | |
YoY Change | ||
Cash From Investing Activities | $0.00 | |
YoY Change | ||
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | $165.8K | $0.00 |
YoY Change | -100.0% | |
NET CHANGE | ||
Cash From Operating Activities | -$162.3K | -$10.46K |
Cash From Investing Activities | $0.00 | |
Cash From Financing Activities | $165.8K | $0.00 |
Net Change In Cash | $3.461K | -$10.46K |
YoY Change | -133.08% | -97.2% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$162.3K | -$10.46K |
Capital Expenditures | ||
Free Cash Flow | ||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023Q4 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2023Q4 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--09-30 | |
CY2023Q4 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2024 | |
CY2023Q4 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2023Q4 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001589150 | |
CY2023Q4 | RGBP |
Convertible Notes Payable Related Parties Less Unamortized Discount Noncurrent
ConvertibleNotesPayableRelatedPartiesLessUnamortizedDiscountNoncurrent
|
usd | |
CY2023Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
usd | |
CY2023Q4 | RGBP |
Increase Decrease In Contributed Capital
IncreaseDecreaseInContributedCapital
|
usd | |
CY2023Q4 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
usd | |
CY2022Q4 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
usd | |
CY2023Q4 | RGBP |
Common Shares Issued For Debt
CommonSharesIssuedForDebt
|
usd | |
CY2022Q4 | RGBP |
Common Shares Issued For Debt
CommonSharesIssuedForDebt
|
usd | |
CY2023Q4 | RGBP |
Preferred Share Issued For Debt
PreferredShareIssuedForDebt
|
usd | |
CY2023Q4 | RGBP |
Cash Paid For Interest
CashPaidForInterest
|
usd | |
CY2022Q4 | RGBP |
Cash Paid For Interest
CashPaidForInterest
|
usd | |
CY2023Q4 | RGBP |
Common Shares Issued For Interests
CommonSharesIssuedForInterests
|
usd | |
CY2023Q4 | RGBP |
Preferred Shares Issued For Interests
PreferredSharesIssuedForInterests
|
usd | |
CY2023Q4 | dei |
Document Type
DocumentType
|
10-Q | |
CY2023Q4 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2023Q4 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-12-31 | |
CY2023Q4 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2023Q4 | dei |
Entity File Number
EntityFileNumber
|
333-191725 | |
CY2023Q4 | dei |
Entity Registrant Name
EntityRegistrantName
|
REGEN BIOPHARMA INC | |
CY2023Q4 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
NV | |
CY2023Q4 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
45-5192997 | |
CY2023Q4 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
4700 Spring Street | |
CY2023Q4 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
St 304 | |
CY2023Q4 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
La Mesa | |
CY2023Q4 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
CA | |
CY2023Q4 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
91942 | |
CY2023Q4 | dei |
City Area Code
CityAreaCode
|
619 | |
CY2023Q4 | dei |
Local Phone Number
LocalPhoneNumber
|
722-5505 | |
CY2023Q4 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2023Q4 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
No | |
CY2023Q4 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2023Q4 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2023Q4 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2023Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
3750565 | shares |
CY2023Q4 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2023Q4 | us-gaap |
Cash
Cash
|
124497 | usd |
CY2023Q3 | us-gaap |
Cash
Cash
|
121037 | usd |
CY2023Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
12298 | usd |
CY2023Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
0 | usd |
CY2023Q3 | RGBP |
Notes Receivable Related Party Current
NotesReceivableRelatedPartyCurrent
|
0 | usd |
CY2023Q3 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
0 | usd |
CY2023Q4 | us-gaap |
Prepaid Rent
PrepaidRent
|
5000 | usd |
CY2023Q3 | us-gaap |
Prepaid Rent
PrepaidRent
|
10000 | usd |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
141795 | usd |
CY2023Q3 | us-gaap |
Assets Current
AssetsCurrent
|
131037 | usd |
CY2023Q4 | RGBP |
Investment Securities Related Party
InvestmentSecuritiesRelatedParty
|
17733 | usd |
CY2023Q3 | RGBP |
Investment Securities Related Party
InvestmentSecuritiesRelatedParty
|
222580 | usd |
CY2023Q4 | us-gaap |
Other Assets
OtherAssets
|
17733 | usd |
CY2023Q3 | us-gaap |
Other Assets
OtherAssets
|
222580 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
159528 | usd |
CY2023Q3 | us-gaap |
Assets
Assets
|
353617 | usd |
CY2023Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
44183 | usd |
CY2023Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
29674 | usd |
CY2023Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
49210 | usd |
CY2023Q3 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
95710 | usd |
CY2023Q4 | us-gaap |
Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
|
4241 | usd |
CY2023Q3 | us-gaap |
Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
|
4241 | usd |
CY2023Q4 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
360353 | usd |
CY2023Q3 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
342588 | usd |
CY2023Q4 | RGBP |
Accrued Payroll Current
AccruedPayrollCurrent
|
1256630 | usd |
CY2023Q3 | RGBP |
Accrued Payroll Current
AccruedPayrollCurrent
|
1256630 | usd |
CY2023Q4 | RGBP |
Other Accrued Expenses
OtherAccruedExpenses
|
41423 | usd |
CY2023Q3 | RGBP |
Other Accrued Expenses
OtherAccruedExpenses
|
41423 | usd |
CY2023Q4 | us-gaap |
Bank Overdrafts
BankOverdrafts
|
1000 | usd |
CY2023Q3 | us-gaap |
Bank Overdrafts
BankOverdrafts
|
1000 | usd |
CY2023Q4 | RGBP |
Due To Investor
DueToInvestor
|
20000 | usd |
CY2023Q3 | RGBP |
Due To Investor
DueToInvestor
|
20000 | usd |
CY2023Q4 | RGBP |
Unearned Income
UnearnedIncome
|
1560091 | usd |
CY2023Q3 | RGBP |
Unearned Income
UnearnedIncome
|
1591731 | usd |
CY2023Q4 | RGBP |
Unearned Income Related Party
UnearnedIncomeRelatedParty
|
0 | usd |
CY2023Q3 | RGBP |
Unearned Income Related Party
UnearnedIncomeRelatedParty
|
15126 | usd |
CY2023Q4 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
1400000 | usd |
CY2023Q3 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
1400000 | usd |
CY2023Q4 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
499880 | usd |
CY2023Q3 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
499880 | usd |
CY2023Q4 | RGBP |
Convertible Notes Payable Related Parties Less Unamortized Discount
ConvertibleNotesPayableRelatedPartiesLessUnamortizedDiscount
|
10000 | usd |
CY2023Q3 | RGBP |
Convertible Notes Payable Related Parties Less Unamortized Discount
ConvertibleNotesPayableRelatedPartiesLessUnamortizedDiscount
|
10000 | usd |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
5247010 | usd |
CY2023Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
5308003 | usd |
CY2023Q4 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
153981 | usd |
CY2023Q3 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
149614 | usd |
CY2023Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
153981 | usd |
CY2023Q3 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
149614 | usd |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
5400991 | usd |
CY2023Q3 | us-gaap |
Liabilities
Liabilities
|
5457617 | usd |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
5800000 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
5800000 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
3750565 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
3750565 | shares |
CY2023Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
3506366 | shares |
CY2023Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
3506366 | shares |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
376 | usd |
CY2023Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
352 | usd |
CY2023Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
800000000 | shares |
CY2023Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
800000000 | shares |
CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
14120412 | usd |
CY2023Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
13908141 | usd |
CY2023Q4 | us-gaap |
Other Additional Capital
OtherAdditionalCapital
|
736326 | usd |
CY2023Q3 | us-gaap |
Other Additional Capital
OtherAdditionalCapital
|
736326 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-20098623 | usd |
CY2023Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-19748863 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-5241463 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-5104000 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
159528 | usd |
CY2023Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
353617 | usd |
CY2023Q4 | us-gaap |
Revenues
Revenues
|
31640 | usd |
CY2022Q4 | us-gaap |
Revenues
Revenues
|
31640 | usd |
CY2023Q4 | RGBP |
Revenues Related Party
RevenuesRelatedParty
|
27425 | usd |
CY2022Q4 | RGBP |
Revenues Related Party
RevenuesRelatedParty
|
27425 | usd |
CY2023Q4 | RGBP |
Total Revenues
TotalRevenues
|
59065 | usd |
CY2022Q4 | RGBP |
Total Revenues
TotalRevenues
|
59065 | usd |
CY2023Q4 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
47528 | usd |
CY2022Q4 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
95513 | usd |
CY2023Q4 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
12419 | usd |
CY2022Q4 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
8738 | usd |
CY2023Q4 | us-gaap |
Professional Fees
ProfessionalFees
|
106900 | usd |
CY2022Q4 | us-gaap |
Professional Fees
ProfessionalFees
|
403680 | usd |
CY2023Q4 | us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
15000 | usd |
CY2022Q4 | us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
15000 | usd |
CY2023Q4 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
181846 | usd |
CY2022Q4 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
522931 | usd |
CY2023Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-122782 | usd |
CY2022Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-463867 | usd |
CY2023Q4 | us-gaap |
Interest Expense
InterestExpense
|
17764 | usd |
CY2022Q4 | us-gaap |
Interest Expense
InterestExpense
|
17359 | usd |
CY2023Q4 | RGBP |
Interest Expense Attributable To Amortization Of Discount
InterestExpenseAttributableToAmortizationOfDiscount
|
-4367 | usd |
CY2022Q4 | RGBP |
Interest Expense Attributable To Amortization Of Discount
InterestExpenseAttributableToAmortizationOfDiscount
|
0 | usd |
CY2023Q4 | us-gaap |
Debt Securities Unrealized Gain Loss
DebtSecuritiesUnrealizedGainLoss
|
-204847 | usd |
CY2022Q4 | us-gaap |
Debt Securities Unrealized Gain Loss
DebtSecuritiesUnrealizedGainLoss
|
0 | usd |
CY2023Q4 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
0 | usd |
CY2022Q4 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
2115806 | usd |
CY2023Q4 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
0 | usd |
CY2022Q4 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
1150 | usd |
CY2023Q4 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-226978 | usd |
CY2022Q4 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
2099597 | usd |
CY2023Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-349760 | usd |
CY2022Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1635730 | usd |
CY2023Q4 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-349760 | usd |
CY2022Q4 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
1448439 | usd |
CY2023Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.10 | |
CY2023Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.10 | |
CY2022Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.4500 | |
CY2022Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.4500 | |
CY2023Q4 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
3596027 | shares |
CY2023Q4 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
3596027 | shares |
CY2022Q4 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
3360540 | shares |
CY2022Q4 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
3360540 | shares |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-5104000 | usd |
CY2023Q4 | RGBP |
Common Shares Issued For Cash
CommonSharesIssuedForCash
|
22726 | usd |
CY2023Q4 | RGBP |
Common Shares Issued For Cash1
CommonSharesIssuedForCash1
|
46091 | usd |
CY2023Q4 | RGBP |
Common Shares Issued For Cash2
CommonSharesIssuedForCash2
|
38205 | usd |
CY2023Q4 | RGBP |
Common Shares Issued For Cash3
CommonSharesIssuedForCash3
|
32629 | usd |
CY2023Q4 | RGBP |
Common Shares Issued For Cash4
CommonSharesIssuedForCash4
|
38101 | usd |
CY2023Q4 | RGBP |
Common Shares Issued For Cash5
CommonSharesIssuedForCash5
|
34543 | usd |
CY2023Q4 | us-gaap |
Profit Loss
ProfitLoss
|
-349760 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-5241463 | usd |
CY2022Q4 | RGBP |
Preferred Shares Issued For Nonemployee Services
PreferredSharesIssuedForNonemployeeServices
|
300000 | usd |
CY2022Q4 | RGBP |
Preferred Shares Issued For Debt
PreferredSharesIssuedForDebt
|
761500 | usd |
CY2022Q4 | RGBP |
Preferred Shares Issued For Interest
PreferredSharesIssuedForInterest
|
380262 | usd |
CY2022Q4 | RGBP |
Common Shares Issued For Interest
CommonSharesIssuedForInterest
|
25369 | usd |
CY2022Q4 | RGBP |
Preferred Shares Issued For Nonemployee Services1
PreferredSharesIssuedForNonemployeeServices1
|
48372 | usd |
CY2022Q4 | us-gaap |
Profit Loss
ProfitLoss
|
1635730 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4884827 | usd |
CY2023Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-349760 | usd |
CY2022Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1635730 | usd |
CY2022Q4 | RGBP |
Preferred Stock Issued As Compensation
PreferredStockIssuedAsCompensation
|
-348372 | usd |
CY2023Q4 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
4367 | usd |
CY2023Q4 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
14509 | usd |
CY2022Q4 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
2240 | usd |
CY2023Q4 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
12298 | usd |
CY2022Q4 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-122575 | usd |
CY2023Q4 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
17765 | usd |
CY2022Q4 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
17359 | usd |
CY2023Q4 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-5000 | usd |
CY2022Q4 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-11856 | usd |
CY2022Q4 | us-gaap |
Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
|
-2115806 | usd |
CY2023Q4 | us-gaap |
Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
|
-46767 | usd |
CY2023Q4 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
1 | pure |
CY2022Q4 | us-gaap |
Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
|
-31640 | usd |
CY2022Q4 | RGBP |
Gain Loss On Forgiveness Of Debt
GainLossOnForgivenessOfDebt
|
1150 | usd |
CY2023Q4 | RGBP |
Unrealized Lossgain On Investment Securities
UnrealizedLossgainOnInvestmentSecurities
|
-204847 | usd |
CY2023Q4 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-162336 | usd |
CY2022Q4 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-10463 | usd |
CY2023Q4 | us-gaap |
Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
|
-46500 | usd |
CY2022Q4 | us-gaap |
Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
|
0 | usd |
CY2023Q4 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
212297 | usd |
CY2022Q4 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | usd |
CY2023Q4 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
165797 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
3460 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-10463 | usd |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
121037 | usd |
CY2022Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
51204 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
124497 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
40741 | usd |
CY2022Q4 | RGBP |
Preferred Share Issued For Debt
PreferredShareIssuedForDebt
|
761500 | usd |
CY2022Q4 | RGBP |
Common Shares Issued For Interests
CommonSharesIssuedForInterests
|
25269 | usd |
CY2022Q4 | RGBP |
Preferred Shares Issued For Interests
PreferredSharesIssuedForInterests
|
380262 | usd |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0529 | pure |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
9.3298 | pure |
CY2023Q4 | us-gaap |
Advertising Expense
AdvertisingExpense
|
0 | usd |
CY2022Q4 | us-gaap |
Advertising Expense
AdvertisingExpense
|
0 | usd |
RGBP |
Net Income Loss Since Inception
NetIncomeLossSinceInception
|
20098623 | usd | |
CY2023Q3 | RGBP |
Common Stock Equals Percentage
CommonStockEqualsPercentage
|
0.80 | pure |
CY2023Q3 | RGBP |
Common Stock Requested Percentage
CommonStockRequestedPercentage
|
2 | pure |
CY2023Q3 | RGBP |
Average Daily Traded Value
AverageDailyTradedValue
|
250000 | usd |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
5800000 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
3750565 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
3750565 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
800000000 | shares |